The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Boĭko O.V.

Moskovskiĭ gorodskoĭ tsentr rasseiannogo skleroza na baze Gorodskoĭ klinicheskoĭ bol'nitsy #11

Tatarinova M.Yu.

Pirogov Russian National Research Medical University, Moscow, Russia

Popova E.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Guseva M.R.

Kafedra oftal'mologii pediatricheskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Gusev E.I.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

The improvement of quality of life of patients with multiple sclerosis over 15-year period

Authors:

Boĭko O.V., Tatarinova M.Yu., Popova E.V., Guseva M.R., Boĭko A.N., Gusev E.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8‑2): 23‑28

DOI: 10.17116/jnevro201811808223

Views: 671

Downloaded: 15

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Boĭko OV, Tatarinova MYu, Popova EV, Guseva MR, Boĭko AN, Gusev EI. The improvement of quality of life of patients with multiple sclerosis over 15-year period. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8‑2):23‑28. (In Russ.)
https://doi.org/10.17116/jnevro201811808223

 
МСФ на ЯМ
Close metadata
Recommended articles:
The effe­ctiveness of tele-rehabilitation for patients with multiple scle­rosis during the COVID-19 pandemic in 2020—2021 was evaluated in this study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):75-81
Comparison between Lichtenstein hernioplasty and lapa­roscopic transabdominal preperitoneal repair acco­rding to quality of life. Russian Journal of Evidence-Based Gastroenterology. 2024;(1):39-47
Factors of physical acti­vity in children after congenital heart disease repair. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(2):158-163
Quality of life in patients with newly diagnosed ovarian cancer acco­mpanied by peri­toneal carcinomatosis. P.A. Herzen Journal of Onco­logy. 2024;(2):27-32
Pelo­therapy and pelo­therapy combined with intravenous laser blood irra­diation at the sana­torium-resort stage of treatment of patients with psoriasis vulgaris. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(2):24-33
Long-term effi­cacy and safety of divo­zilimab during 2-year treatment of multiple scle­rosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):86-96
A case of COVID-associated ence­phalopathy in a patient with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):159-163
Opti­cal cohe­rence tomo­graphy angiography in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(2):63-70
Quality of life in patients with postoperative unilateral diaphragm rela­xation. Piro­gov Russian Journal of Surgery. 2024;(5):21-27
Asse­ssment of patient sati­sfaction during therapeutic plasmapheresis. Russian Journal of Preventive Medi­cine. 2024;(5):46-52

In this article, the authors compared the results of the studies on quality of life (SF-36 questionnaire) of large groups of patients with multiple sclerosis conducted in 2000—2003 and 2012—2016 years.

Keywords:

multiple sclerosis
SF-36
quality of life

Authors:

Boĭko O.V.

Moskovskiĭ gorodskoĭ tsentr rasseiannogo skleroza na baze Gorodskoĭ klinicheskoĭ bol'nitsy #11

Tatarinova M.Yu.

Pirogov Russian National Research Medical University, Moscow, Russia

Popova E.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Guseva M.R.

Kafedra oftal'mologii pediatricheskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Gusev E.I.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

List of references:

  1. NICE Citizens Council. Quality Adjusted Life Years (QALYs) and the Severity of Illness. London: National Institute for Health and Care Excellence (NICE); 2008.
  2. Post MW. Definitions of quality of life: what has happened and how to move on. Top Spinal Cord Inj Rehabil. 2014;20(3):167-180.
  3. Ruggeri M, Bisoffi G, Fontecedro L, Warner R. Subjective and objective dimensions of quality of life in psychiatric patients: a factor analytical approach: the South Verona Outcome Project 4. Br J Psychiatry. 2001;178:268-275.
  4. Lantéri-Minet M, Duru G, Mudge M. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. 2011;31:837-850.
  5. Sitthipornvorakul E, Klinsophon T, Sihawong R, Janwantanakul P. The effects of walking intervention in patients with chronic low back pain: A meta-analysis of randomized controlled trials. Musculoskelet Sci Pract. 2017;34:38-46.
  6. Tan SB, Williams AF, Kelly D. Effectiveness of multidisciplinary interventions to improve the quality of life for people with Parkinson’s disease: a systematic review. Int J Nurs Stud. 2014;51(1):166-174.
  7. World Health Organisation. Neurological disorders: public health challenges. Switzerland: World Health Organisation; 2006.
  8. Lee Mortensen G, Rasmussen PV. The impact of quality of life on treatment preferences in multiple sclerosis patients. Patient Prefer Adherence. 2017;11:1789-1796.
  9. Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, Rao SM. Neuropsychology of multiple sclerosis: looking back and moving forward. J Int Neuropsychol Soc. 2017;23(9-10):832-842.
  10. Whitehurst DG, Noonan VK, Dvorak MF, Bryan S. A review of preference-based health-related quality of life questionnaires in spinal cord injury research. Spinal Cord. 2012;50(9):646-654.
  11. Fiest KM, Greenfield J, Metz LM, Patten SB, Jetté N, Marrie RA. Discriminative ability of quality of life measures in multiple sclerosis. Health Qual Life Outcomes. 2017;15(1):246.
  12. Boyko A, Kesselring J, Paty DW, Siva A, Singhal B, Thompson A, Willoughby E. Multiple sclerosis and public health. Educational and management implications. World Health Organization, Department of Mental Health, Neuroscience and Neurological Disorders. 1999;2:1-11.
  13. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. New Engl J Med. 2000;343:1430-1438.
  14. Klevan G, Jacobsen CO, Aarseth JH, Myhr KM, Nyland H, Glad S, Lode K, Figved N, Larsen JP, Farbu E. Health related quality of life in patients recently diagnosed with multiple sclerosis. Acta Neurol Scand. 2014;129:21-26.
  15. Popova EV. Factors determining quality of life in patients with remitting multiple sclerosis. Zhurnal Nevrologii I Psikhiatr im. S.S. Korsakova. 2008;108(4):77-80. (In Russ.)
  16. Malkova NA, Riabukchina OV, Ionova TI, Kishtovich AV. Study of the quality of life of patients with multiple sclerosis in Novosibirsk. Nevrologicheskyi Zhurnal. 2005;10(4):17-20. (In Russ.)
  17. Tatarinova MYu. Study of the quality of life and pharmacoeconomical analysis in patients with multiple sclerosis: Dis... d-ra med. nauk. M. 2003. (In Russ.)
  18. Baliazin VA, Goncharova ZA, Rudenko OYu. Factors influencing on the quality of life of patients with multiple sclerosis. Sovremennie Problemi Nauki i Obrazovania. 2012;5:22-25. (In Russ.)
  19. Julian LJ, Vella L, Vollmer T, Hadjimichael O, Mohr DC. Employment in multiple sclerosis. Exiting and re-entering the work force. J Neurol. 2008;255:1354-1360.
  20. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol. 2004;61(5):679-686.
  21. Benito-Leon J, Mitchell AJ, Rivera-Navarro J, Morales-Gonzalez JM. Impaired health-related quality of life predicts progression of disability in multiple sclerosis. Eur J Neurol. 2012;20(1):79-86.
  22. Gusev EI, Boĭko AN. Multiple sclerosis at the time of world-wide use of disease modifying treatment. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2009;109(7 suppl 2):4-9. (In Russ.)
  23. Matute-Blanch C, Montalban X, Comabella M. Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system. Handb Clin Neurol. 2017;146:67-84.
  24. Karussis D, Biermann LD, Bohlega S, Boiko A, Chofflon M, Fazekas F, Freedman M, Gebeily S, Gouider R, Havrdova E, Jakab G, Karabudak R, Miller A. A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting. Eur J Neurol. 2006;13:61-71.
  25. Soerensen PS. New management algorithms in multiple sclerosis. Curr Opin Neurol. 2014;27(3):246-259.
  26. Boyko AN. Selection of the optimal drug for multiple sclerosis therapy. Meditsinkii Sovet. 2015;5:78-86. (In Russ.)
  27. Boyko OV. Syties of the quality of life in multiple sclerosis patients. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2014;114:10:105-113. (In Russ.)
  28. Ruet A, Deloire M, Hamel D, Ouallet JC, Petry K, Brochet B. Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: A 7-year longitudinal study. J Neurol. 2013;260:776-784.
  29. Perneger TV, Leplege A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol. 1995;48(8):1051-1060.
  30. Ionova TI, Novik AA, Suchonos IA. Quality of life of patients with cancer. Voprosi Onkologii. 1998;44(6):749-752. (In Russ.)
  31. Tatarinova MYu, Fokin IV, Boĭko AN. Quality of life in multiple sclerosis and pharmaco-economic studies. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2002;2(2):76-80. (In Russ.)
  32. Riabukhina OV. The influence of multiple sclerosis on the quality of life of patients from Novosibirsk: Dis... kand. med. nauk. Novosibirsk. 2003. (In Russ.)
  33. Popova EV, Riabukhina OV, Vorob’eva OV, Malkova NA, Boĭko AN. Changes in quality of life in patients with remitted multiple sclerosis during the specific treatment with disease-modifying drugs: a comparative study of populations of Moscow and Novosibirsk. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2010;110(5):67-70. (In Russ.)
  34. Popova EV, Boyko AN, Boyko OV. The results of a randomized open multicenter comparative study on the tolerability and safety of gilenya (fingolimod) in patients with remitting multiple sclerosis. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2015; 115(2 Pt 2):45-50. (In Russ.)
  35. Boyko OV, Boyko AN, Guseva MR. Changes in the quality of life indexes in multiple sclerosis patients under treatment with natalizumab. Nevrologicheskyi Zh. 2018;1:42-46. https://doi.org/10.18821/1560-9545-2018-23-1. (In Russ.)
  36. Lee Mortensen G, Rasmussen PV. The impact of quality of life on treatment preferences in multiple sclerosis patients. Patient Prefer Adherence. 2017;11:1789-1796.
  37. Yamout B, Issa Z, Herlopian A, El Bejjani M, Khalifa A, Ghadieh AS, Habib RH. Predictors of quality of life among multiple sclerosis patients: A comprehensive analysis. Eur J Neurol. 2013;20:756-764.
  38. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444-1452.
  39. Lebedeva AV, Shchukin IA, Soldatov MA, Boĭko OV, Petrov SV, Khozova AA, Ismailov AM, Shikhkerimov RK, Boĭko AN Asthenia, emotional disorders and quality of life of patients with multiple sclerosis. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2014;114(10 Pt 2):99-104. (In Russ.)
  40. Rieckmann P, Boyko A, Centonze D, Coles A, Elovaara I, Havrdová E, Hommes O, Lelorier J, Morrow SA, Oreja-Guevara C, Rijke N, Schippling S. Future MS care: a consensus statement of the MS in the 21st Century Steering Group. J Neurol. 2013;260(2):462-469.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.